Regeneron Pharmaceuticals
REGN
#231
Rank
S$104.51 B
Marketcap
$951.08
Share price
-0.90%
Change (1 day)
-14.84%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total debt

Total debt on the balance sheet as of September 2024 : S$3.66 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total debt is S$3.66 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Regeneron Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$3.56 B-1.43%
2022-12-31S$3.62 B-0.77%
2021-12-31S$3.64 B2.34%
2020-12-31S$3.56 B270.53%
2019-12-31S$0.96 B-0.56%
2018-12-31S$0.96 B2.87%
2017-12-31S$0.94 B35.13%
2016-12-31S$0.69 B35.64%
2015-12-31S$0.51 B-15.12%
2014-12-31S$0.60 B-5.4%
2013-12-31S$0.63 B14.31%
2012-12-31S$0.55 B-0.85%
2011-12-31S$0.56 B173.62%
2010-12-31S$0.20 B34.68%
2009-12-31S$0.15 B2001.41%
2008-12-31S$7.28 M-97.47%
2007-12-31S$0.28 B-6.16%
2006-12-31S$0.30 B-7.9%
2005-12-31S$0.33 B2.06%
2004-12-31S$0.32 B-10.18%
2003-12-31S$0.36 B4.6%
2002-12-31S$0.34 B-6.47%
2001-12-31S$0.37 B7890.97%
2000-12-31S$4.64 M-31.93%
1999-12-31S$6.82 M-1.55%
1998-12-31S$6.93 M-26.56%
1997-12-31S$9.44 M-22.46%
1996-12-31S$12.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$81.84 B 2,133.65%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.76 B-51.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.01 B 145.97%๐Ÿ‡บ๐Ÿ‡ธ USA
S$48.44 B 1,222.15%๐Ÿ‡บ๐Ÿ‡ธ USA
S$43.57 B 1,089.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$34.50 B 841.59%๐Ÿ‡ซ๐Ÿ‡ท France